REINFECTION RESULTS IN ACCUMULATION OF UNINTEGRATED VIRAL-DNA IN CYTOPATHIC AND PERSISTENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF CEM CELLS

被引:122
作者
PAUZA, CD
GALINDO, JE
RICHMAN, DD
机构
[1] SALK INST BIOL STUDIES,DEV BIOL LAB,SAN DIEGO,CA 92138
[2] UNIV CALIF SAN DIEGO,DEPT PATHOL,SAN DIEGO,CA 92103
[3] UNIV CALIF SAN DIEGO,DEPT MED,SAN DIEGO,CA 92103
关键词
D O I
10.1084/jem.172.4.1035
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
High levels of unintegrated viral DNA accumulate during human immunodeficiency virus type 1 (HIV1) infection of CEM T cells. Reinfection of already infected cells is required to attain these levels and reinfection also promotes the development of HIV-induced cytopathology. Rates of virus production, however, are independent of the accumulation of unintegrated viral DNA. Neutralizing antibody added soon after infection reduced viral DNA levels without appreciably affecting the production of cell-free viral p24 antigen or reverse transcriptase activity. Only 50 pM AZT were required to reduce the accumulation ofunintegrated viral DNA by 50% in contrast to the 25 nM required to inhibit virus production by 50%. Cytopathology,-as measured by number of syncytia in infected cell cultures, was correlated with highly elevated levels of unintegrated viral DNA. The minimal levels ofunintegrated viral DNA present constitutively in the persistently infected HCEM cell line were consonant with the absence of cytopathic effects in these cells. These data demonstrate that inhibiting the reinfection ofalreadyinfected cells modulates cytopathic HIV-1 infection to a form that is persistent and noncytopathic. © 1990, Rockefeller University Press., All rights reserved.
引用
收藏
页码:1035 / 1042
页数:8
相关论文
共 49 条
[1]   MOLECULAR-CLONING OF LYMPHADENOPATHY-ASSOCIATED VIRUS [J].
ALIZON, M ;
SONIGO, P ;
BARRESINOUSSI, F ;
CHERMANN, JC ;
TIOLLAIS, P ;
MONTAGNIER, L ;
WAINHOBSON, S .
NATURE, 1984, 312 (5996) :757-760
[2]  
COLLIER A, 1989, 29TH INT C ANT AG CH
[3]   PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
COOMBS, RW ;
COLLIER, AC ;
ALLAIN, JP ;
NIKORA, B ;
LEUTHER, M ;
GJERSET, GF ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) :1626-1631
[4]  
FISCHL M, 1990, 6TH INT C AIDS SAN F
[5]   THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISCHL, MA ;
RICHMAN, DD ;
GRIECO, MH ;
GOTTLIEB, MS ;
VOLBERDING, PA ;
LASKIN, OL ;
LEEDOM, JM ;
GROOPMAN, JE ;
MILDVAN, D ;
SCHOOLEY, RT ;
JACKSON, GG ;
DURACK, DT ;
KING, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) :185-191
[6]   BIOLOGICAL AND BIOCHEMICAL-CHARACTERIZATION OF A CLONED LEU-3- CELL SURVIVING INFECTION WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME RETROVIRUS [J].
FOLKS, TM ;
POWELL, D ;
LIGHTFOOTE, M ;
KOENIG, S ;
FAUCI, AS ;
BENN, S ;
RABSON, A ;
DAUGHERTY, D ;
GENDELMAN, HE ;
HOGGAN, MD ;
VENKATESAN, S ;
MARTIN, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :280-290
[7]   FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS [J].
GALLO, RC ;
SALAHUDDIN, SZ ;
POPOVIC, M ;
SHEARER, GM ;
KAPLAN, M ;
HAYNES, BF ;
PALKER, TJ ;
REDFIELD, R ;
OLESKE, J ;
SAFAI, B ;
WHITE, G ;
FOSTER, P ;
MARKHAM, PD .
SCIENCE, 1984, 224 (4648) :500-503
[8]  
GIBOA E, 1979, CELL, V18, P93
[9]   LYMPHADENOPATHY-ASSOCIATED-VIRUS INFECTION AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
GLUCKMAN, JC ;
KLATZMANN, D ;
MONTAGNIER, L .
ANNUAL REVIEW OF IMMUNOLOGY, 1986, 4 :97-117
[10]   EFFECT OF T4 COUNT AND COFACTORS ON THE INCIDENCE OF AIDS IN HOMOSEXUAL MEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
GOEDERT, JJ ;
BIGGAR, RJ ;
MELBYE, M ;
MANN, DL ;
WILSON, S ;
GAIL, MH ;
GROSSMAN, RJ ;
DIGIOIA, RA ;
SANCHEZ, WC ;
WEISS, SH ;
BLATTNER, WA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (03) :331-334